<?xml version="1.0" encoding="UTF-8"?>
<p id="Par19">In addition to gangliosidoses, ganglioside accumulation diseases, also diseases like infantile epilepsy, Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD) and multiple sclerosis (MS) may involve disturbed ganglioside metabolism.
 <sup>
  <xref ref-type="bibr" rid="CR48">48</xref>
 </sup> On the other hand, the peripheral neuropathy Guillain–Barré syndrome (GBS) is an example of a disease associated with production of autoreactive antiganglioside antibodies (AGAs).
 <sup>
  <xref ref-type="bibr" rid="CR49">49</xref>
 </sup> As studied by Ceccarelli et al. already in the 70’s, gangliosides can promote the regeneration of injured neurons.
 <sup>
  <xref ref-type="bibr" rid="CR26">26</xref>
 </sup> Exogenously administered gangliosides mimic endogenous gangliosides through their insertion into the plasma membranes after first adhering as micelles.
 <sup>
  <xref ref-type="bibr" rid="CR25">25</xref>
 </sup> During recent years, exogenous purified gangliosides have been used experimentally to treat certain neurological diseases.
 <sup>
  <xref ref-type="bibr" rid="CR48">48</xref>
 </sup>
</p>
